1451 - 1460 of 8587 Results
Title
Year
- Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa2009OPENTitle: Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North AfricaJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 477Issue #: 2Start Page: 57End Page: 60Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2009.11.066Best OA location URL: https://europepmc.org/articles/pmc2970621?pdf=renderCitation Count: 25
- Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor2011OPENTitle: Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factorJournal Name: NeurosciencePublisher: Elsevier BVVol: 194Issue #:Start Page: 220End Page: 226Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2011.07.072Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3408714Citation Count: 34
- Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease2013OPENTitle: Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 258Issue #:Start Page: 385End Page: 400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2013.11.038Best OA location URL: http://doi.org/10.1016/j.neuroscience.2013.11.038Citation Count: 51
- Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?2011OPENTitle: Do Stable Patients With a Premorbid Depression History Have a Worse Outcome After Deep Brain Stimulation for Parkinson Disease?Journal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 69Issue #: 2Start Page: 357End Page: 361Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3182160456Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3593636Citation Count: 23
-
OPENTitle: A GCase Chaperone Improves Motor Function in a Mouse Model of SynucleinopathyJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 840End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-014-0294-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-014-0294-x.pdfCitation Count: 97
- Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid2015OPENTitle: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal FluidJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 13Issue #: 1Start Page: 217End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-015-0404-4Best OA location URL: http://link.springer.com/content/pdf/10.1007/s13311-015-0404-4.pdfCitation Count: 38
-
OPENTitle: Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular DystoniaJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 15Issue #: 2Start Page: 452End Page: 458Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-018-0620-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-018-0620-9.pdfCitation Count: 10
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation2017OPENTitle: The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep DeprivationJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 11Start Page: 2196End Page: 2205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2017.13Best OA location URL: https://www.nature.com/articles/npp201713.pdfCitation Count: 29
-
OPENTitle: Morphological Alterations in the Thalamus, Striatum, and Pallidum in Autism Spectrum DisorderJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 11Start Page: 2627End Page: 2637Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/npp.2016.64Best OA location URL: https://www.nature.com/articles/npp201664.pdfCitation Count: 145
-
OPENTitle: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working MemoryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 9Start Page: 2224End Page: 2231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2016.14Best OA location URL: https://www.nature.com/articles/npp201614.pdfCitation Count: 27